Chunghwa Chemical Synthesis & Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Chunghwa Chemical Synthesis & Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$90.44 Million ≈ $2.85 Million USD) by net assets (NT$3.18 Billion ≈ $100.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)

Cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Chunghwa Chemical Synthesis & Biotech Co (1762) stock price for real-time trading data and today's change.

Chunghwa Chemical Synthesis & Biotech Co Ltd Cash Flow Conversion Ratio Explained

Chunghwa Chemical Synthesis & Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Chunghwa Chemical Synthesis & Biotech Co worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Kilitch Drugs (India) Limited NSE:KILITCH	-0.025x
RBZ Jewellers Limited NSE:RBZJEWEL	-0.056x
Pulmonx Corp NASDAQ:LUNG	-0.133x
Resource Mining Corporation Ltd AU:RMI	-0.078x
Gowing Bros Ltd AU:GOW	-0.003x
Hitech Corporation Limited NSE:HITECHCORP	0.093x
Formosa Prosonic Industries KLSE:9172	0.009x
Ribbon Acquisition Corp Unit NASDAQ:RIBBU	-0.001x

Annual Cash Flow Conversion Efficiency for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. Review 1762 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$3.09 Billion ≈ $97.27 Million	NT$142.61 Million ≈ $4.49 Million	0.046x	-66.84%
2024-12-31	NT$3.36 Billion ≈ $105.76 Million	NT$467.65 Million ≈ $14.73 Million	0.139x	+702.20%
2023-12-31	NT$3.35 Billion ≈ $105.55 Million	NT$-77.50 Million ≈ $-2.44 Million	-0.023x	-110.07%
2022-12-31	NT$3.19 Billion ≈ $100.60 Million	NT$733.78 Million ≈ $23.12 Million	0.230x	+203.46%
2021-12-31	NT$2.89 Billion ≈ $91.19 Million	NT$219.18 Million ≈ $6.91 Million	0.076x	+36.88%
2020-12-31	NT$2.50 Billion ≈ $78.72 Million	NT$138.24 Million ≈ $4.36 Million	0.055x	-58.42%
2019-12-31	NT$2.02 Billion ≈ $63.49 Million	NT$268.13 Million ≈ $8.45 Million	0.133x	+12.49%
2018-12-31	NT$1.98 Billion ≈ $62.50 Million	NT$234.66 Million ≈ $7.39 Million	0.118x	+35.20%
2017-12-31	NT$1.82 Billion ≈ $57.38 Million	NT$159.34 Million ≈ $5.02 Million	0.087x	-40.70%
2016-12-31	NT$1.77 Billion ≈ $55.80 Million	NT$261.31 Million ≈ $8.23 Million	0.148x	+245.00%
2015-12-31	NT$1.86 Billion ≈ $58.72 Million	NT$79.70 Million ≈ $2.51 Million	0.043x	+199.40%
2014-12-31	NT$1.62 Billion ≈ $50.91 Million	NT$23.08 Million ≈ $727.18K	0.014x	-83.17%
2013-12-31	NT$1.71 Billion ≈ $53.91 Million	NT$145.24 Million ≈ $4.58 Million	0.085x	-47.02%
2012-12-31	NT$1.68 Billion ≈ $52.79 Million	NT$268.46 Million ≈ $8.46 Million	0.160x	+85.46%
2011-12-31	NT$1.68 Billion ≈ $52.82 Million	NT$144.84 Million ≈ $4.56 Million	0.086x	-47.25%
2010-12-31	NT$1.68 Billion ≈ $53.01 Million	NT$275.61 Million ≈ $8.68 Million	0.164x	-57.67%
2009-12-31	NT$1.19 Billion ≈ $37.63 Million	NT$462.07 Million ≈ $14.56 Million	0.387x	+329.84%
2008-12-31	NT$837.53 Million ≈ $26.39 Million	NT$75.39 Million ≈ $2.38 Million	0.090x	--

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology

Market Cap

$76.34 Million

NT$2.42 Billion TWD

Market Cap Rank

#20059 Global

#1174 in Taiwan

Share Price

NT$31.50

Change (1 day)

-2.63%

52-Week Range

NT$24.30 - NT$42.30

All Time High

NT$102.50